Handbook of Clinical medicine

tumours Vaccinating to prevent hepatitis B (and associated complications) Use hepatitis B vaccine 1mL into deltoid; repeat at 1 & 6 mon ths (child: 0.5mL ≈ 3 into the anterolateral thigh). Indications: Everyone (WHO advice, even in areas of ‘low’ endemicity—in 2014 this meant that 82% of the world’s children received protection against HBV). This contrasts with the approach in eg the UK and USA of targeting at-risk groups (p278). The immunocompromised and others may need further doses. Serology helps time boosters and fi nds non-responders (correlates with older age, smoking, and  sex). Know your own antibody level! Table 6.15 Post-immunization anti-HBs titres and actions Anti-HBs (IU/L) Actions and comments (advice diff ers in some areas) >1000 Good level of immunity; retest in ~4yrs. 100–1000 Good level of immunity; if level approaches 100, retest in 1yr. <100 Inadequate; give booster and retest. <10 Non-responder; give another set of 3 vaccinations. Retest; if <10 get consent to check hepatitis B status: HBSAg +ve means chronic infection; anti-HB core +ve represents past infection and immunity. If a non-re- sponder is deemed susceptible to HBV, and has recently come in contact with risky bodily fl uids, off er 2 doses of anti-hep
